MedCity News February 3, 2022
Arundhati Parmar

Formus Labs is expecting to get the regulatory nod from the FDA to be able to sell its fully-automated 3D planning technology for joint replacement surgeries in the second quarter and has partnered with orthopedic surgery heavyweight for a global distribution program.

A New Zealand startup that makes fully automated 3D orthopedic surgery planning software announced Wednesday that it has raised $5 million and struck a partnership with Zimmer Biomet for co-development and global distribution of its technology.

Formus Labs, which bills itself as the world’s first world’s “first automated 3D planner for joint replacement surgeries” received the investment from lead investor GD1 (Global from Day 1), and others including Punakaiki Fund, Icehouse Ventures, Pacific Channel, and Flying Kiwis.The company...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Investments, Technology, Trends
Technologies Transforming the Surgical Experience
WASP Highlights Advances in Healthcare 3D Printing at Italy’s Exposanità 2024
3D Systems Brings 3D Printed PEEK Cranial Implant to the U.S. with FDA Clearance
3D Printing Market Hits $14.7B Amid Challenges in 2023
World’s First Bioprinted Trachea Transplant Marks a New Era in Medical Innovation

Share This Article